dimethyl fumarate / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

11 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dimethyl fumarate / Generic mfg.
ACTRN12618000534280: Study to Assess the Efficacy and Safety of Tecfidera in Patients with Amyotrophic Lateral Sclerosis - TEALS Study

Not yet recruiting
2
90
 
University of Sydney, FightMND
Amyotrophic Lateral Sclerosis
 
 
ACTRN12608000644369: A Phase 2a, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of BG00012 when given with methotrexate to subjects with active rheumatoid arthritis who have had an inadequate response to conventional disease-modifying anti-rheumatic drug therapy.

Not yet recruiting
2
150
 
Biogen Idec, Inc, Biogen Idec, Inc
Rheumatoid arthritis
 
 
2017-003386-10: Dimethylfumarate for the treatment of Palmoplantar Pustulosis Dimethylfumarat in der Behandlung der Palmoplantaren Pustulose

Ongoing
2
25
Europe
Skilarence, EMEA/H/C/002157, Gastro-resistant tablet, Skilarence 30 mg, Skilarence 120 mg
Medical University of Vienna, Almirall
Palmoplantar Pustulosis Palmoplantare Pustulose, Palmoplantar Pustulosis Palmoplantare Pustulose, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
MS200527-0086, NCT02975349 / 2016-001448-21: A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple Sclerosis

Terminated
2
267
Europe, RoW
Evobrutinib, M2951, Placebo, Tecfidera
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany
Relapsing-remitting Multiple Sclerosis
01/18
04/24
haojunwei5, NCT04891497: Combination of the Immune Modulator Dimethyl Fumarate With Intraarterial Treatment in Acute Ischemic Stroke

Withdrawn
2
50
NA
Dimethyl Fumarate, Placebo
Xuanwu Hospital, Beijing
Acute Ischemic Stroke
12/21
12/21
haojunwei2, NCT04890379: Dimethyl Fumarate for the Treatment of Intracerebral Hemorrhage

Withdrawn
2
50
RoW
Dimethyl fumarate, Placebo
Xuanwu Hospital, Beijing
Intracerebral Hemorrhage
12/21
12/21
LADIGAGA, NCT04292080: Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy

Recruiting
2
60
Europe
Dimethyl Fumarate (TECFIDERA™), No active : no treatment
Assistance Publique - Hôpitaux de Paris
Age-related Macular Degeneration (AMD)
10/25
10/27
2022-002171-11: Safety and efficacy of dimethyl fumarate in tratment of dementia due to Alzheimer's Disease Skuteczność i bezpieczeństwo fumaranu dimetylu w leczeniu otępienia w chorobie Alzheimera

Not yet recruiting
2
100
Europe
dimethyl fumarate, Gastro-resistant capsule, hard
Medical University of Łódź, Medical Research Agency
dementia and mild cognitice impairment due to Alzheimer's Disease demencja i łagodne zaburzenia poznawcze w Chorobie Alzheimera, dementia and mild cognitice impairment due to Alzheimer's Disease demencja i łagodne zaburzenia poznawcze w Chorobie Alzheimera, Psychiatry and Psychology [F] - Behaviours [F01]
 
 
haojunwei3, NCT04890366: Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic Stroke

Recruiting
1/2
50
RoW
Dimethyl Fumarate
Xuanwu Hospital, Beijing
Acute Ischemic Stroke
12/22
12/22
haojunwei4, NCT04890353: Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke

Terminated
1/2
2
RoW
Dimethyl fumarate
Xuanwu Hospital, Beijing
Acute Ischemic Stroke
02/23
02/23
IMCY-MS-001, NCT05417269: IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study

Active, not recruiting
1/2
150
RoW
IMCY-0141, Imotope, Placebo, Dimethyl Fumarate, DMF
Imcyse SA
Multiple Sclerosis, Relapsing-Remitting
05/25
12/25

Download Options